Old Web
English
Sign In
Acemap
>
Paper
>
Mo1890 VEDOLIZUMAB DOSE ESCALATION IMPROVES DISEASE ACTIVITY FOR “PARTIAL RESPONDERS” IN ULCERATIVE COLITIS
Mo1890 VEDOLIZUMAB DOSE ESCALATION IMPROVES DISEASE ACTIVITY FOR “PARTIAL RESPONDERS” IN ULCERATIVE COLITIS
2020
Courtney Perry
Kyle Fischer
Ahmed Elmoursi
Leon Su
Cody Kern
Alden C. Currier
Praneeth Kudaravalli
Pradeep Yarra
Nishant Tripathi
Olalekan Akanbi
Mohammed Abdelsalam
Terrence A. Barrett
Keywords:
Vedolizumab
disease activity
Ulcerative colitis
Internal medicine
General surgery
Medicine
dose escalation
Gastroenterology
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]